Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28471
Title: Systematic quantification of histologic ventricular fibrosis in isolated mitral valve prolapse and sudden cardiac death.
Austin Authors: Han, Hui-Chen ;Parsons, Sarah A;Curl, Claire L;Teh, Andrew W ;Raaijmakers, Antonia J A;Koshy, Anoop N ;Leong, Trishe Y-M;Burrell, Louise M ;O'Donnell, David ;Vohra, Jitendra K;Kalman, Jonathan M;Sanders, Prashanthan;Hare, David L ;Farouque, Omar ;Delbridge, Lea M D;Lim, Han S 
Affiliation: Victorian Institute of Forensic Medicine and Monash University Department of Forensic Medicine, Victoria, Australia..
Department of Cardiology, Northern Health and University of Melbourne, Victoria, Australia..
Department of Cardiology, Eastern Health and Monash University, Victoria, Australia..
Anatomical Pathology
Cardiology
Department of Physiology, University of Melbourne, Victoria, Australia..
Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, South Australia, Australia
Department of Cardiology, Royal Melbourne Hospital and University of Melbourne, Victoria, Australia..
Medicine (University of Melbourne)
Issue Date: Apr-2021
Date: 2020
Publication information: Heart Rhythm 2021; 18(4): 570-576
Abstract: Cardiac fibrosis in mitral valve prolapse (MVP) is implicated in the development of sudden cardiac death (SCD); however, the pattern remains poorly characterized. The purpose of this study was to systematically quantify left and right ventricular fibrosis in individuals with isolated MVP and SCD (iMVP-SCD), whereby other potential causes of death are excluded, compared to a control cohort. Individuals with iMVP-SCD were identified from the Victorian Institute of Forensic Medicine, Australia, and matched for age, sex, and body mass index to control cases with noncardiac death. Cardiac tissue sections were analyzed to determine collagen deposition in the left ventricular free wall (anterior, lateral, and posterior portions), interventricular septum, and right ventricle. Within the iMVP-SCD cases, the endocardial-to-epicardial distribution of fibrosis within the left ventricle was specifically characterized. Seventeen cases with iMVP-SCD were matched 1:1 with 17 controls, yielding 149 samples and 1788 histologic regions. The iMVP-SCD group had increased left ventricular (anterior, lateral, and posterior; all P <.001) and interventricular septum fibrosis (P <.001), but similar amounts of right ventricular fibrosis (P = .62) compared to controls. In iMVP-SCD, left ventricular fibrosis was significantly higher in the lateral and posterior walls compared to the anterior wall and interventricular septum (all P <.001). Within the lateral and posterior walls, iMVP-SCD cases had a significant endocardial-to-epicardial gradient of cardiac fibrosis (P <.01) similar to other known conditions that cause cardiac remodeling. Our study indicates that nonuniform left ventricular remodeling with both localized and generalized left ventricular fibrosis is important in the pathogenesis of SCD in individuals with MVP.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28471
DOI: 10.1016/j.hrthm.2020.12.021
ORCID: 0000-0001-5884-5784
0000-0003-4074-3610
0000-0002-8741-8631
0000-0003-1863-7539
0000-0001-9554-6556
0000-0003-2821-1451
0000-0002-8532-7891
Journal: Heart Rhythm
PubMed URL: 33359875
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/33359875/
Type: Journal Article
Subjects: Cardiac fibrosis
Mitral valve disease
Mitral valve prolapse
Sudden death
Valvular heart disease
Appears in Collections:Journal articles

Show full item record

Page view(s)

54
checked on Nov 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.